THE INFLUENCE OF THE KALLIKREIN-TRYPSIN INACTIVATOR TRASYLOL ON THE SERUM CHOLINESTERASE

In a study of 28 patients suffering from a wide variety of diseases, the kallikrein-trypsin inactivator Trasylol (FBA) was found to have an inhibitory action on the serum cholinesterase 30 minutes after the administration of the drug. The average fall in serum cholinesterase at this time was 25.4 pe...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of anaesthesia : BJA Vol. 40; no. 6; pp. 456 - 458
Main Authors CHASAPAKIS, G., AUGUSTAKI, O., KEKIS, N., PHILIPPOU, P., MORAITIS, H., FLORAS, A., MAKKOUS, A.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.1968
Oxford University Press
Subjects
Adolescent
Adult
Aged
Apnea - chemically induced
Aprotinin - pharmacology
Cholinesterase Inhibitors - pharmacology
Cholinesterases - blood
Female
Humans
Male
Middle Aged
Succinylcholine - adverse effects
Online AccessGet full text

Cover

More Information
Summary:In a study of 28 patients suffering from a wide variety of diseases, the kallikrein-trypsin inactivator Trasylol (FBA) was found to have an inhibitory action on the serum cholinesterase 30 minutes after the administration of the drug. The average fall in serum cholinesterase at this time was 25.4 per cent. Values had returned to normal levels at 60 minutes.
Bibliography:istex:C5F750177891D68B5A89769555EA63458E624594
ArticleID:40.6.456
ark:/67375/HXZ-RTFTFJ4H-3
ISSN:0007-0912
1471-6771
DOI:10.1093/bja/40.6.456